The FDA cleared the first glucose monitoring system specifically designed for weight management from Signos, providing a new ...

The FDA approved the first over-the-counter glucose monitoring system designed to help with weight management. Developed by health technology company Signos, the system combines the Stelo by Dexcom ...

Merck KGaA agreed to a deal with RNA biotech Skyhawk Therapeutics that could top out at $2 billion. Roche’s Genentech terminated a cell therapy partnership with Adaptive Biotechnologies, ending what ...

The U.S. Food and Drug Administration has cleared the Signos Glucose Monitoring System, an over-the-counter glucose mo ...